Skip to main content
Equibles

SANOFICONR · Sanofi Consumer Healthcare India Limited · Financials

Use SANOFICONR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SANOFICONR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
3,609.40 INR +71.40 (+2.02%) At close · Nov 13
Rebalance outlook locked
Market Cap
83.13B INR
Shares
23.03M
Volume · Nov 13 3810 Avg daily vol (3M) 16.53K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
8.78B +21.2%
FY2025 Revenue FY2024–FY2025
Net Income
2.4B +32.7%
FY2025 Net Income FY2024–FY2025
Operating Cash Flow
2.77B -36.8%
FY2025 Operating Cash Flow FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2025 FY2024
INR 9.79B 8.78B 7.25B
INR 130M 117M 45M
INR 17M 20M 39M
INR 3.76B 3.2B 2.47B
INR 961M 802M 658M
INR 2.8B 2.4B 1.81B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2025: 1.27B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.